New hope for patients with hard-to-treat autoimmune anemia?
Disease control
Not yet recruiting
This early-phase study tests a new drug, enatumab, in 3 adults with relapsed or refractory warm antibody autoimmune hemolytic anemia (wAIHA), a condition where the immune system attacks red blood cells. Current treatments often stop working or cause side effects. The goal is to s…
Phase: PHASE2 • Sponsor: Bing Han • Aim: Disease control
Last updated May 17, 2026 07:58 UTC